| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer
|
Hsu, I-Chow Joe
|
|
2014
|
13 |
1 |
p. 27-31
5 p.
|
article
|
| 2 |
Characterization of implant displacement and deformation in gynecologic interstitial brachytherapy
|
Damato, Antonio L.
|
|
2014
|
13 |
1 |
p. 100-109
10 p.
|
article
|
| 3 |
Comparison of dose-escalated, image-guided radiotherapy vs. dose-escalated, high-dose-rate brachytherapy boost in a modern cohort of intermediate-risk prostate cancer patients
|
Marina, Ovidiu
|
|
2014
|
13 |
1 |
p. 59-67
9 p.
|
article
|
| 4 |
Decline in acute urinary toxicity: A long-term study in 2011 patients with prostate brachytherapy within a provincial institution
|
Chan, Elisa K.
|
|
2014
|
13 |
1 |
p. 46-52
7 p.
|
article
|
| 5 |
Does dose matter? Editorial comments to Morris et al. Whole prostate D 90 and V 100: A dose–response analysis of 2000 consecutive 125I monotherapy cases
|
Stone, Nelson N.
|
|
2014
|
13 |
1 |
p. 42-43
2 p.
|
article
|
| 6 |
Editorial Board
|
|
|
2014
|
13 |
1 |
p. A2-
1 p.
|
article
|
| 7 |
Evaluating adjacent organ radiation doses from postoperative intracavitary vaginal vault brachytherapy for endometrial cancer
|
Caon, Julianna
|
|
2014
|
13 |
1 |
p. 94-99
6 p.
|
article
|
| 8 |
Examining the evidence in pursuit of the highest possible brachytherapy standards
|
Buyyounouski, Mark K.
|
|
2014
|
13 |
1 |
p. 15-16
2 p.
|
article
|
| 9 |
Guide for Authors
|
|
|
2014
|
13 |
1 |
p. A5-
1 p.
|
article
|
| 10 |
Late toxicity and cosmetic outcomes related to interstitial multicatheter brachytherapy for partial breast irradiation
|
Hepel, Jaroslaw T.
|
|
2014
|
13 |
1 |
p. 23-26
4 p.
|
article
|
| 11 |
Locally advanced cervical cancer in renal transplant patients: A dilemma between control and toxicity
|
Maroun, Pierre
|
|
2014
|
13 |
1 |
p. 88-93
6 p.
|
article
|
| 12 |
Masthead
|
|
|
2014
|
13 |
1 |
p. A1-
1 p.
|
article
|
| 13 |
MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer
|
Takiar, Vinita
|
|
2014
|
13 |
1 |
p. 68-74
7 p.
|
article
|
| 14 |
Rebuttal to Drs Stone and Stock
|
Spadinger, Ingrid
|
|
2014
|
13 |
1 |
p. 44-45
2 p.
|
article
|
| 15 |
RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma—year-5 toxicity and cosmesis
|
Rabinovitch, Rachel
|
|
2014
|
13 |
1 |
p. 17-22
6 p.
|
article
|
| 16 |
Salvage brachytherapy for recurrent prostate cancer
|
Vargas, Carlos
|
|
2014
|
13 |
1 |
p. 53-58
6 p.
|
article
|
| 17 |
Table of Contents
|
|
|
2014
|
13 |
1 |
p. A3-A4
nvt p.
|
article
|
| 18 |
The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma
|
|
|
2014
|
13 |
1 |
p. 1-14
14 p.
|
article
|
| 19 |
Validation study of ultrasound-based high-dose-rate prostate brachytherapy planning compared with CT-based planning
|
Batchelar, Deidre
|
|
2014
|
13 |
1 |
p. 75-79
5 p.
|
article
|
| 20 |
Volume-based pulsed-dose-rate brachytherapy boosting concurrent chemoradiation as a definitive treatment modality in cervical cancer
|
Refaat, Tamer
|
|
2014
|
13 |
1 |
p. 80-87
8 p.
|
article
|
| 21 |
Whole prostate D 90 and V 100: A dose–response analysis of 2000 consecutive 125I monotherapy patients
|
Morris, W. James
|
|
2014
|
13 |
1 |
p. 32-41
10 p.
|
article
|
Journal description